Merit Medical (MMSI) Q2 Revenue Up 13%

Merit Medical Systems (NASDAQ:MMSI), a medical device developer serving cardiovascular and endoscopy markets, reported results for its second quarter ended June 30, 2025, on July 30, 2025. The company posted GAAP revenue of $382.5 million, up 13.2% from the prior year and above the analyst consensus of $374.2 million (GAAP). Non-GAAP earnings per share (EPS) reached $1.01, beating the $0.85 estimate. Reported GAAP EPS, however, declined 11.6% to $0.54. The quarter showed solid broad-based growth, especially in the Cardiac Intervention and Endoscopy device lines, and marked progress on profitability (non-GAAP, excluding one-time expenses). Management characterized the period as one of strong outperformance. and increased its full-year revenue and non-GAAP earnings outlook.

Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q2 2025 earnings report.

Merit Medical Systems is a global provider of medical devices, supplying specialized products for cardiovascular and endoscopy procedures. Its portfolio includes tools such as vascular intervention catheters, cardiac access systems, and endoscopy devices for minimally invasive therapies. It operates both directly and through distributors in the United States and internationally.

Continue reading

Source Fool.com